GATE BT 2025 • Q38 MCQ • 2 Marks

Section 4: Bioprocess Engineering and Process Biotechnology

Mass transfer in bioprocesses (kLa)

Subtopic: Fundamentals of Mass transfer in bioprocesses (kLa)

Question Statement:

An octapeptide composed of these L-amino acids - Lys, Thr, Ser, Met, Arg, Trp, Tyr, Glu - was subjected to analyses with the following outcomes: P. The N-terminal sequencing analysis by Sanger's method yielded 'Ser' at the N-terminus Q. Chymotrypsin treatment gave a pentapeptide, a 'Tyr' containing dipeptide and a free 'Glu' R. Cyanogen bromide treatment gave two tetrapeptides S. Trypsin treatment gave two tripeptides and a dipeptide Which one of the following is the correct octapeptide sequence?

Options:

  • (A) Ser-Tyr-Arg-Met-Lys-Thr-Trp-Glu
  • (B) Ser-Arg-Lys-Met-Tyr-Thr-Trp-Glu
  • (C) Ser-Met-Lys-Arg-Thr-Tyr-Trp-Glu
  • (D) Ser-Arg-Met-Lys-Trp-Thr-Tyr-Glu

Official Answer Key:

A

Step-by-Step Solution & Explanation

### **Official Solution & Concept Analysis (GATE BT 2025 Q.38)** **1. Governing Concept**: - **Topic**: Biochemistry & Glycolysis Regulation (Phosphofructokinase-1) - **Phosphofructokinase-1 (PFK-1)** catalyzes the committed, rate-limiting step of glycolysis: $\text{Fructose 6-phosphate} + \text{ATP} \rightarrow \text{Fructose 1,6-bisphosphate} + \text{ADP}$ - Allosteric regulation of PFK-1: - **Allosteric Activators**: **Fructose 2,6-bisphosphate ($\text{F-2,6-BP}$)** (the most potent physiological activator), **AMP**, and **ADP**. - **Allosteric Inhibitors**: **ATP** (high energy charge signals sufficient energy) and **Citrate** (signals abundant TCA cycle precursors). **2. Option Analysis**: - **Option (A) is INCORRECT**: High ATP allosterically inhibits PFK-1 by binding to a low-affinity regulatory site. - **Option (B) is INCORRECT**: Citrate is an allosteric inhibitor, not an activator. - **Option (C) is CORRECT**: Fructose 2,6-bisphosphate is the most potent allosteric activator, relieving ATP inhibition and increasing affinity for fructose 6-phosphate. - **Option (D) is INCORRECT**: AMP stimulates PFK-1, it does not inhibit. **3. Final Answer**: - **Correct Choice**: **C**

Practice This in Real CBT Exam Interface

Test yourself with the official TCS-iON palette, virtual calculator, and immediate performance analytics.

Launch CBT Mock Test